These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 36340839)

  • 21. Co-crystallization of a neutral mol-ecule and its zwitterionic tautomer: structure and Hirshfeld surface analysis of 5-methyl-4-(5-methyl-1
    Asiri AM; Alzahrani KAH; Faidallah HM; Alamry KA; Jotani MM; Tiekink ERT
    Acta Crystallogr E Crystallogr Commun; 2019 May; 75(Pt 5):565-570. PubMed ID: 31110787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of 4-[(2,4-di-chloro-phen-yl)(5-hy-droxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)meth-yl]-5-methyl-2-phenyl-2,3-di-hydro-1H-pyrazol-3-one.
    Kumar B; Mahajan H; Paul S; Kant R; Gupta VK
    Acta Crystallogr E Crystallogr Commun; 2015 Oct; 71(Pt 10):o805-6. PubMed ID: 26594489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-{[(E)-(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)methyl-idene]amino}-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one.
    Fun HK; Hemamalini M; Asiri AM; Khan SA
    Acta Crystallogr Sect E Struct Rep Online; 2010 Jun; 66(Pt 7):o1602-3. PubMed ID: 21587838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of (4Z)-4-{[(2-chloro-phen-yl)amino](furan-2-yl)methyl-idene}-3-methyl-1-phenyl-4,5-di-hydro-1H-pyrazol-5-one.
    Zhang HQ; Yang X; Wu Q; Chen HL
    Acta Crystallogr E Crystallogr Commun; 2015 Mar; 71(Pt 3):o177-8. PubMed ID: 25844235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,5-Dimethyl-2-phenyl-1H-pyrazol-3(2H)-one-4,4'-(propane-2,2-di-yl)bis-[1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one] (1/1).
    Lyczko K
    Acta Crystallogr Sect E Struct Rep Online; 2013 Jan; 69(Pt 1):o127-8. PubMed ID: 23476388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure refinement with SHELXL.
    Sheldrick GM
    Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):3-8. PubMed ID: 25567568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SHELXT - integrated space-group and crystal-structure determination.
    Sheldrick GM
    Acta Crystallogr A Found Adv; 2015 Jan; 71(Pt 1):3-8. PubMed ID: 25537383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. iotbx.cif: a comprehensive CIF toolbox.
    Gildea RJ; Bourhis LJ; Dolomanov OV; Grosse-Kunstleve RW; Puschmann H; Adams PD; Howard JA
    J Appl Crystallogr; 2011 Dec; 44(Pt 6):1259-1263. PubMed ID: 22199401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.
    Hadi V; Koh YH; Sanchez TW; Barrios D; Neamati N; Jung KW
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6854-7. PubMed ID: 20864343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.
    Yuan WJ; Yasuhara T; Shingo T; Muraoka K; Agari T; Kameda M; Uozumi T; Tajiri N; Morimoto T; Jing M; Baba T; Wang F; Leung H; Matsui T; Miyoshi Y; Date I
    BMC Neurosci; 2008 Aug; 9():75. PubMed ID: 18671880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury.
    Yoshida H; Yanai H; Namiki Y; Fukatsu-Sasaki K; Furutani N; Tada N
    CNS Drug Rev; 2006; 12(1):9-20. PubMed ID: 16834755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, computational and biological evaluation of new anxiolytics.
    Geronikaki A; Babaev E; Dearden J; Dehaen W; Filimonov D; Galaeva I; Krajneva V; Lagunin A; Macaev F; Molodavkin G; Poroikov V; Pogrebnoi S; Saloutin V; Stepanchikova A; Stingaci E; Tkach N; Vlad L; Voronina T
    Bioorg Med Chem; 2004 Dec; 12(24):6559-68. PubMed ID: 15556772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
    Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
    Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents.
    Gürsoy A; Demirayak S; Capan G; Erol K; Vural K
    Eur J Med Chem; 2000 Mar; 35(3):359-64. PubMed ID: 10785562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.
    Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML
    J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Methyl-4-(5-methyl-3-oxo-2-phenyl-2,3-di-hydro-1
    Powell GL; Rix BA
    IUCrdata; 2020 Feb; 5(Pt 2):x200121. PubMed ID: 36340839
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.